FDA panel recommends review of Tamiflu

At a Thursday meeting, FDA's Pediatric Advisory Committee reiterated its recommendation that an extensive review of Tamiflu oseltamivir, including

Read the full 194 word article

How to gain access

Continue reading with a
two-week free trial.